Background
==========

DiGeorge syndrome (DGS) and Velocardiofacial syndrome (VCFS) are genetic disorders affecting pharyngeal and neurobehavioural development \[[@B1]\] that result in conotruncal congenital heart defects (CHD), velopharyngeal insufficiency, hypoparathyroidism, thymic aplasia or hypoplasia, craniofacial dysmorphism, learning difficulties and psychiatric disorders \[[@B2],[@B3]\]. Interstitial microdeletions in 22q11.2 have been identified as the underlying cause in most cases of DGS \[[@B4]\], VCFS \[[@B5]\] and apparently isolated conotruncal CHD \[[@B6]\].

Deletions in 22q11.2 cluster into a standard 3 Mb deletion in 87% of the cases, a smaller, proximally nested 1.5 Mb deletion in 7% and other atypical deletions, nested, overlapping or adjacent to the typically deleted region (TDR) \[[@B7],[@B8]\]. By non-allelic homologous recombination (NAHR) after asynchronous replication \[[@B9]\], large low-copy repeats in 22q11.2 (LCR22s A to D) mediate recurrent deletions \[[@B7]\], whereas recently described uncommon deletions are flanked by smaller LCRs (E to H) \[[@B10]\] or alternative breakpoints \[[@B5],[@B11]-[@B24]\].

Different point mutations \[[@B25],[@B26]\], balanced translocation breakpoints \[[@B27]-[@B29]\] and shortest regions of deletion overlap (SRO) \[[@B11]-[@B16],[@B30],[@B31]\] in 22q11.2 have been compared in order to identify candidate genes for the 22q11.2 deletion syndrome phenotype. However, no clear genotype-phenotype correlation has been found \[[@B5],[@B32]\] and identical alterations, even within members of the same family, show high phenotypic diversity and variable expressivity or incomplete penetrance \[[@B33]-[@B35]\]. Systematic clinical sorting of patients with non-overlapping deletions has recently shown that an ascertainment bias could be eclipsing different phenotypes or even what would be different syndromes \[[@B19],[@B23],[@B36]\].

22q11.2 duplication syndrome has also been recently characterized as a different clinical entity \[[@B37]\] with features overlapping 22q11.2 deletion syndrome \[[@B38]\]. Since fewer duplications have been reported, it is suspected that the diagnosis of this condition is also biased \[[@B39]-[@B43]\], a fact supported by its clinical diversity, generally ranging from a milder, cognitive/behavioral to an apparently normal phenotype in these patients \[[@B41],[@B43]-[@B48]\]. This lower severity suggests that duplications with sizes that range from 3 to 6 Mb are less deleterious than deletions \[[@B37]\] and therefore are more likely to be inherited at reduced penetrance \[[@B43]\]. Again, LCRs work as recombination substrates for these rearrangements \[[@B37]\], and different sizes have also been described \[[@B43],[@B49]\].

In this paper we present two patients referred to us for genetic diagnosis of 22q11.2 deletion syndrome. The first patient was found to harbor an atypical deletion and the second one an inherited atypical duplication in the distal segment of the TDR covering LCRs C and D \[[@B7]\]. We discuss screening diagnostic strategies for patients referred for 22q11.2 deletion testing as well as the clinical implications of these findings for a potential genotype-phenotype correlation.

Methods
=======

Samples and pictures from patients and their families were obtained after informed consent. Ethical approval was obtained for this study from the IRB at Hospital Universitario La Paz in Madrid (HULP-CEIC-PI347). Research was performed in compliance with the Declaration of Helsinki.

Patient 1
---------

A male infant was the first child of healthy, non-consanguineous parents of age 39 and 36 years. Due to menstrual dysfunction in the mother, artificial insemination was performed with an oocyte donation from a woman of unknown age. The child was born at 37 weeks of gestation and weighed 2450 g (10th--25th centile). At age 3 months he was referred to Pediatric Cardiology because of respiratory distress and an ASD (ostium secundum type) together with multiple muscular and perimembranous VSDs. He was examined by a clinical geneticist and noted to have some dysmorphic features such as a triangular facies with a slighty small chin and a broad nose (Figure [1a, b](#F1){ref-type="fig"}). He had a poor head control which he finally achieved at the age of 4 months. Cardiovascular surgery was performed at that time. At age 7 months he was re-evaluated; his growth parameters were: height 62.5 cm (\< 5th centile), weight 5540 g (\< 3rd centile) and OFC 41 cm (5--10th centile). He was not sitting unsupported yet.

![**Facial appearance of Patients 1 and 2**. Patient 1 (a, b); Patient 2 (c).](1471-2350-10-48-1){#F1}

Patient 2
---------

A male newborn was born to healthy 37 year-old parents after Cesarean section due to lack of progress at 33 weeks of gestation. Birthweight was 2290 g (75th centile). He was referred to the Neonatology intensive care unit because of respiratory distress. He was noted to have a right cleft lip with a complete cleft palate, and upslanting palpebral fissures with no other significant features on examination. He made good progress and was finally discharged two weeks later. He was reviewed in clinic at age five months. His development was within the normal range. His growth parameters were: height 62 cm, weight 6500 g and OFC 42.5 cm (all measurements between the 10th and 25th centiles) (Figure [1c](#F1){ref-type="fig"}). His cleft lip had been repaired and the cleft palate operation was scheduled for the age of nine months. A later review at age 13 months and a half showed a good progress and a normal development.

Karyotype and FISH
------------------

Cytogenetic analysis was performed after standard harvesting of peripheral blood lymphocytes. Metaphase chromosomes were G-banded. Fluorescence in situ hybridization was performed on peripheral blood lymphocytes, with probe N25 (D22S1660--D22S1646) (Kreatech Diagnostics, Amsterdam, The Netherlands). A minimum of 15 metaphase cells were assessed under a fluorescence microscope (Leica Microsystems, Wetzlar, Germany).

MLPA
----

Multiplex ligation-dependent probe amplification was performed on DNA from peripheral blood lymphocytes, extracted with Puregene DNA Isolation Kit (Gentra Systems, Minneapolis, MN). Kits P023B, P250 and P324-A1 for DGS/VCFS/CES (MRC-Holland, Amsterdam, The Netherlands) were used. The three kits test 65 loci on 22q11 (8 on the CES region, 37 within the TDR and 20 adjacent distal to the TDR), 2 on 22q13, 7 on 4q, 1 on 7p, 5 on 8p, 2 on 9q, 9 on 10p, 1 on 10q, 6 on 17p and 2 on 18q, most of them involved in the phenotypes of DGS and VCFS. Data analysis was made against up to 5 control samples using the MRC Coffalyser v8 and v9 software \[[@B50]\] or an in-house Excel spreadsheet.

Microsatellite segregation studies
----------------------------------

Eighteen microsatellite markers (CATCH 10, CATCH 20, CATCH 42, CATCH 41, CATCH 11, D22S311, CATCH 12, CATCH 13, CATCH 14, CATCH 39, D22S1709, CATCH 38, CATCH 37, CATCH 36, CATCH 35, D22S446bis, D22S306, D22S303) spanning the region in the vicinity of LCR22-C and LCR22-D were studied. Markers named CATCH were designed by Torres-Juan *et al*\[[@B51]\].

Array Hybridization profiling and Data Analysis
-----------------------------------------------

DNAs were quantified using PicoGreen (Invitrogen Corporation, Carlsbad, CA) and a genome-wide scan of 620,901 tag SNPs was conducted on the probands, using the Illumina Human610-Quad BeadChip according to the manufacturer\'s specifications (Illumina, San Diego, CA). GenCall scores \< 0.15 at any locus were considered \"no calls\". Image data was analyzed using the Chromosome Viewer tool contained in Beadstudio 3.2 (Illumina, San Diego, CA). The metric used was the log *R*ratio which is the log (base 2) ratio of the observed normalized *R*value for a SNP divided by the expected normalized *R*value \[[@B52]\]. In addition, an allele frequency analysis was applied for all SNPs. All genomic positions were based upon NCBI Build 36 (dbSNP version 126).

Results
=======

Karyotype and FISH analysis with probe N25 in both patients and their parents showed normal results.

However, MLPA testing of both patients and their parents with kits P023B, P250 and P324-A1 showed a deletion of 5 probes (SNAP29, LZTR1, LCRD probe 06317-L10754, HIC2 and LCRD probe 06321-L05796) on Patient 1 (Figure [2a, b](#F2){ref-type="fig"}), and a duplication of 3 probes (SNAP29, LZTR1 and LCRD probe 06317-L10754) on Patient 2 (Figure [2a, b](#F2){ref-type="fig"}) and his mother, uncle, two aunts and maternal grandfather (not shown). These MLPA loci fall within a shortest segment of 675.1 kb for the deletion and 207.4 kb for the duplication, both including the region between LCR22-C and LCR22-D \[[@B7]\]. On examination, the mother, uncle, two aunts and maternal grandfather of Patient 2 were all phenotypically normal.

![**MLPA results of Patients 1 and 2**. Gene dosage of Patient 1 and Patient 2 observed by MLPA. Kit P250 (a) showed deletion of probes SNAP29, LZTR1 and HIC2 in Patient 1 and duplication of probes SNAP29 and LZTR1 in Patient 2, whereas kit P324-A1 (b) showed deletion of both LCRD probes in Patient 1 and duplication of only the proximal one in Patient 2. Data from both kits were analysed with Coffalyser v8 and v9, respectively.](1471-2350-10-48-2){#F2}

On the other hand, microsatellite segregation studies were informative for STRs D22S311, D22S1709 and CATCH 38 in Patient 1, and confirmed a *de novo*paternal deletion. STR CATCH 42 showed a triallelic result for both Patient 2 and his mother, whereas CATCH 11 showed such a result only in the mother. Fluorescence intensity of the alleles of markers CATCH 41, D22S311 and CATCH 13 suggested a trisomic result (Table [1](#T1){ref-type="table"}).

###### 

Alleles of STR markers studied in Patient 1 and father and Patient 2 and relatives.

                        Position                 Patient 1   Father 1   Patient 2         Mother 2          Father 2   Maternal aunt 2a   Maternal aunt 2b   Maternal uncle 2   Maternal grandfather 2
  --------------------- ------------------------ ----------- ---------- ----------------- ----------------- ---------- ------------------ ------------------ ------------------ ------------------------
  CATCH 10              191,164,96               120 122     NA         120 122           122               120 122    122                122                122                122
                                                                                                                                                                                
  CATCH 20              19,245,111               *160*       160        NA                160               160 162    160                160                160                160
                                                                                                                                                                                
  PCQAP\*               19,266,745               N           N          N                 N                 N          N                  N                  N                  N
                                                                                                                                                                                
  LCR-C\*\*             19,354,000--19,417,000                                                                                                                                  
                                                                                                                                                                                
  CATCH 42              19,449,222               *99*        93 99      **93 97 101**     **93 99 101**     97 99      **93 99 101**      **93 99 101**      **93 99 101**      **93 101**
                                                                                                                                                                                
  CATCH 41              19,450,208               NA          169 173    **169 173**       **169 173**       173 177    **169 173**        **169 173**        **169 173**        **169 173**
                                                                                                                                                                                
  CATCH 11              19,469,542               *197*       195 197    **195 199**       **191 195 199**   195 199    **191 195 199**    **191 195 199**    **191 195 199**    **195 199**
                                                                                                                                                                                
  D22S311               19,503,575               **251**     249 255    **251 253**       **249 253**       251        **249 253**        **249 253**        **249 253**        **249 253**
                                                                                                                                                                                
  CATCH 12              19,566,292               *116*       116        *116*             *116*             116        *116*              *116*              *116*              *116*
                                                                                                                                                                                
  CATCH 13              19,567,154               *143*       138 143    **138 143**       **138 143**       143        **138 143**        **138 143**        **138 143**        **138 143**
                                                                                                                                                                                
  SNAP29\*              19,572,014               **del**     N          **dup**           **dup**           N          **dup**            **dup**            **dup**            **dup**
                                                                                                                                                                                
  CATCH 14              19,595,454               *212*       212 215    **200 216 227**   **208 216 227**   200 210    **208 216 227**    **208 216 227**    **208 216 227**    **216 220 227**
                                                                                                                                                                                
  CATCH 39              19,640,114               *106*       106 110    **94 102 110**    **94 102 106**    106 110    **94 102 106**     **94 102 106**     **94 102 106**     **94 102**
                                                                                                                                                                                
  LZTR1\*               19,679,191               **del**     N          **dup**           **dup**           N          **dup**            **dup**            **dup**            **dup**
                                                                                                                                                                                
  D22S1709              19,735,440               **120**     128        **126 128 132**   **126 128 132**   128 132    **126 128 132**    **126 128 132**    **126 128 132**    **126 132**
                                                                                                                                                                                
  CATCH 38              19,745,025               **157**     159        *159*             *159*             155 159    *159*              *159*              *159*              *159 163*
                                                                                                                                                                                
  CATCH 37              19,759,833               NA          226 234    *230 245*         *230 245*         230 245    *230 245*          *230 245*          *230 245*          *230 245*
                                                                                                                                                                                
  LCR-D\*\*             19,777,000                                                                                                                                              
                                                                                                                                                                                
  LCRD 06317-L10754\*   19,779,435               **del**     N          **dup**           **dup**           N          **dup**            **dup**            **dup**            **dup**
                                                                                                                                                                                
  CATCH 36              20,126,412               *109*       109        *109*             *109*             109        *109*              *109*              *109*              *109*
                                                                                                                                                                                
  HIC2\*                20,130,631               **del**     N          N                 N                 N          N                  N                  N                  N
                                                                                                                                                                                
  LCR-D\*\*             20,242,000                                                                                                                                              
                                                                                                                                                                                
  LCRD 06321-L05796\*   20,247,101               **del**     N          N                 N                 N          N                  N                  N                  N
                                                                                                                                                                                
  CATCH 35              20,341,833               *136*       136 150    *136 150*         *136 143*         143 150    *136 143*          *136 143*          *136 143*          *136 143*
                                                                                                                                                                                
  D22S446bis            20,343,665               *157*       157 185    157 180           157 161           165 180    157 161            157 161            157 161            157 161
                                                                                                                                                                                
  PPIL2\*               20,379,687               N           N          N                 N                 N          N                  N                  N                  N
                                                                                                                                                                                
  D22S306               20,887,523               *106*       106        NA                NA                NA         *106*              *106*              *106*              *106*
                                                                                                                                                                                
  D22S303               21,599,366               212 222     212 222    NA                NA                NA         212 222            212 222            212 222            212

Alleles are expressed in fragment bp. STR markers are located according to the NCBI Build 36.1, together with the MLPA probes (\*) and the LCRs (\*\*). The shortest informative deletion and duplication segments by MLPA and STRs are D22S311-LCRD 06321-L05796 and CATCH 42-LCRD 06317-L10754, respectively. Bold text indicates haploinsufficiency or trisomy, two alleles listed in bold mean that homozygosity is suspected in one of them, so there are really three alleles. Regular text indicates biallelism. Italic indicates non informative results. del: deletion; dup: duplication; N: normal; NA: not available.

SNP genotyping by array-CGH narrowed down the deletion size to 1092.027 kb (rs165626-rs12170039) in Patient 1 (Figure [3a](#F3){ref-type="fig"}) and the duplication size to 377.634 kb (rs17819969-rs11703181) for Patient 2 (Figure [3b](#F3){ref-type="fig"}). These results are consistent with MLPA and STRs studies. Other genomic copy number variations (CNV) observed in these patients had been previously described in the normal population \[[@B53],[@B54]\] according to the Database of Genomic Variants \[[@B55]\] (data not shown). The relative location of each marker and the deleted and duplicated segments are shown in Figure [4](#F4){ref-type="fig"}.

![**Array-CGH SNP genotyping of Patients 1 and 2**. Chromosome 22 plot of Patients 1 (a) and 2 (b). The upper panels show the genic dosage (Log R ratio) and the homozygous/heterozygous distribution (B allele frequency) for all the SNPs genotyped. Both parameters are used together for interpretation of deletions and duplications. The region showing copy number alterations is zoomed in below, indicating the flanking SNPs and the genes in the region. A copy number decrease and loss of heterozygosity was found in Patient 1 (pink shading, a), whereas a copy number increase with four different allele populations was found in Patient 2 (blue shading, b).](1471-2350-10-48-3){#F3}

![**Detailed map of the distal TDR in 22q11.2**. The relative location of the informative MLPA probes (blue font), STRs (black font) and SNPs (gray, small-sized font) sizing the shortest deletion and duplication size are shown above the line. Green boxes indicate LCRs, purple boxes indicate the discussed genes and the pink bar and the blue bar below the line indicate the deleted and the duplicated segment, respectively. Cen: centromere; tel: telomere.](1471-2350-10-48-4){#F4}

Discussion
==========

The whole phenotypic spectrum of 22q11.2 deletion syndrome is contributed by multiple dosage-sensitive genes across the 22q11.2 region, that are required for normal development \[reviewed in \[[@B1]\]\]. Moreover, non-overlapping, atypical deletions do have significantly overlapping phenotypes, suggesting either, several candidate genes for the syndrome \[[@B13],[@B14],[@B56]\], a common developmental pathway \[[@B17]\] or a positional gene effect in 22q11.2 \[[@B17],[@B57]-[@B59]\]. On the other hand, phenotypes shown by identical deletions in 22q11.2 have been suggested to be modified by parental imprinting \[[@B60]\], unbalanced regulatory effects \[[@B15],[@B59]\], recessive mutations or polymorphisms unmasked by hemizygosity \[[@B59],[@B60]\], environmental factors \[[@B60]\] or stochastic events during morphogenesis \[[@B15],[@B61]\]. Susceptibility to other syndromes in patients with 22q11.2 deletions has also been proposed \[[@B58],[@B62],[@B63]\]. Phenotypic discordance has been observed in monozygotic twins with 22q11.2 deletion syndrome \[[@B33],[@B64]\], a finding that is consistent with both a genetic and an environmental influence.

In the recent years, several candidate genes reproducing part of the phenotype in animal models \[[@B13],[@B14],[@B26],[@B56],[@B65]\] or suspected to change disease predisposition \[[@B66]-[@B69]\] have been identified in 22q11.2. In this context, correlations made within a contiguous gene syndrome will always be subjected to phenotype exceptions.

Rauch *et al*\[[@B19]\] described a likely genotype-phenotype correlation, by comparing the phenotypes of non-overlapping deletions in 22q11.2 (Table [2](#T2){ref-type="table"}). They concluded that deletions covering the whole TDR or the proximally nested 1.5 Mb segment result in a phenotype characterized by conotruncal CHDs and typical VCFS, mainly by effects of haploinsufficiency of *TBX1*, a gene previously involved in the expression of these features when mutated \[[@B26]\], whereas distally nested deletions including *CRKL*would present with a milder, atypical phenotype with uncommon CHDs, developmental delay and mental impairment. Likewise, distal deletions which are adjacent to, and do not include the TDR, would generally have associated non-specific CHDs and very uncommon features of 22q11.2 deletion syndrome such as choanal atresia. Within these deletions, the shortest proximal segment has been associated with mild learning difficulties \[[@B19]\]. Recently, additional characteristic features of this new condition such as prematurity, prenatal and postnatal growth retardation, developmental delay, mild skeletal abnormalities and characteristic facial dysmorphic features have been described \[[@B23]\] (Table [2](#T2){ref-type="table"}).

###### 

Observed clinical features in atypical deletions of the LCR intervals in 22q11.2.

  LCR interval   Rauch 2005 \[[@B19]\]   Ben-Shachar 2008 \[[@B23]\]   García-Miñaur 2002 \[[@B18]\]          Kurahashi 1996 \[[@B70]\]    D\'Angelo 2007 \[[@B21]\]   Patient 1                                                              
  -------------- ----------------------- ----------------------------- -------------------------------------- ---------------------------- --------------------------- ---------------------------------------------------------------------- -----------------------------
                 \- ctCHD                \- ctCHD                                                                                                                                                                                             
  A-B            \- typical VCFS         \- typical VCFS                                                                                                                                                                                      
                                                                                                                                                                                                                                              
                                         \- Atypical CHD                                                      \- ctCHD                                                                                                                        
  B-C                                    \- Mild dysmorphism                                                  \- Mild facial dysmorphism                                                                                                      
                                         \- DD                                                                \- Father normal                                                                                                                
                                                                                                                                                                                                                                              
                                         \- Learning disabilities                                                                          \- CTAFS: TOF, PA           \- Mild facial features                                                \- Atypical CHD
  C-D                                                                                                                                      \- Facial dysmorphism       \- Neurodevelopmental, behavioural and psychiatric spectrum disorder   \- Atypical facial features
                                                                                                                                                                       \- Mother with depressive disorder                                     
                                                                                                                                                                                                                                              
                                                                       \- Prematurity                                                                                                                                                         
                 \- Mild DD              \- Mild DD                                                                                                                                                                                           
                                                                       \- Prenatal and postnatal GR                                                                                                                                           
                 \- Choanal atresia                                                                                                                                                                                                           
                                                                       \- Learning difficulties and/or DD                                                                                                                                     
  D-E            \- Atypical CHD                                       \- Specific skeletal abnormalities                                                                                                                                     
                                                                       \- Characteristic facial dysmorphism                                                                                                                                   
                                                                       \- Higher risk for TA                                                                                                                                                  
                                                                                                                                                                                                                                              
  E-F                                                                                                                                                                                                                                         

CTAFS: conotruncal anomaly face syndrome; ctCHD: conotruncal congenital heart defect; DD: developmental delay; GR: growth retardation; PA: pulmonary atresia; TA: truncus arteriosus; TOF: tetralogy of Fallot; VCFS: Velocardiofacial syndrome.

The absence of a genotype-phenotype correlation highlights the incomplete penetrance associated with alterations in the 22q11.2 region. As an example, an apparently identical atypical deletion in two reported familial cases was found to present both inter- and intrafamilial variability \[[@B18],[@B19]\]. This atypical deletion which spanned the B-D segment, and which should have been mainly involved in learning disability and mental retardation, was found to be associated with a conotruncal CHD in a child of a deleted father with normal phenotype \[[@B18]\] (Table [2](#T2){ref-type="table"}). Whereas, in the second case, the child developed a more neurobehavioural phenotype, with an undiagnosed father with schizophrenia \[[@B19]\]. Both patients had mild facial dysmorphism with overlapping features of DGS/VCFS.

In line with this, the only two reported distally nested C-D deletions similar to that found in Patient 1 are also phenotypically discordant \[[@B21],[@B70]\]. Both were located within this segment that should be associated with the neurobehavioural expression. The patient from D\'Angelo *et al*\[[@B21]\] had mild facial features and a complex neurodevelopmental, behavioural and psychiatric spectrum, with a major depressive disorder in her transmitting mother, but the patient described by Kurahashi *et al*\[[@B70]\] had a typical conotruncal anomaly face syndrome with pulmonary atresia, tetralogy of Fallot, and facial dysmorphic features. Our patient had a non-specific CHD and mild facial features, barely suggestive of the 22q11.2 deletion syndrome (Table [2](#T2){ref-type="table"}). All these findings, within such a small sample size, do not reveal strong evidences but suggest that genetic changes in 22q11.2 are incompletely penetrant \[[@B19]\] or that maybe genotype-phenotype correlations are invalid for this specific region \[[@B21]\].

The reason for all these exceptions in the distal TDR might be the presence of *CRKL*, a gene that has been involved in multisystemic affection of cardiac neural crest derivatives when null-mutated in mice \[[@B65]\]. Otherwise, other genes in this region seem to be responsible for a more particular phenotype: certain SNP haplotypes within genes *PIK4CA*\[[@B66],[@B67]\] and *SNAP29*\[[@B68],[@B69]\] have been recently suggested to confer a higher risk of developing schizophrenia (Figure [4](#F4){ref-type="fig"}).

Recently, high resolution molecular diagnostic techniques have contributed to map the rearrangements in 22q11.2 more precisely. In fact, high resolution comparative genomic hybridization (HR-CGH), real-time quantitative PCR (qPCR) and high density MLPA (HD-MLPA) have shown that around 7% of the typical 3 Mb A-D deletions have atypical distal breakpoints covering *HIC2*, suggesting that this gene located within LCR22-D might be involved in the phenotypic variability among these patients \[[@B20],[@B71],[@B72]\]. *Hic2*may be required for heart development in mouse \[Lammerts van Beuren K and Scambler PJ, personal communication\]. *HIC2*might be also involved in the phenotypic variability of Patient 1 and other patients reported to carry the C-D deletion \[[@B21],[@B70]\], as well as in patients with other atypical deletions \[[@B15],[@B17],[@B19],[@B20],[@B58]\].

Screening for duplications at 22q11.2 has no standardized procedure, as these patients show clinical manifestations, only some of which are compatible with 22q11.2 deletion syndrome within a generally milder phenotype \[[@B37],[@B41],[@B43],[@B48]\]. Different duplication sizes have been reported \[[@B43],[@B48],[@B49]\], all of them showing a higher tendency to be inherited than deletions \[[@B43]\]. Phenotype correlations to the sizes and locations of these duplications are even harder to find than in deletions, as the whole clinical spectrum is still unknown and many of these individuals overlap normality \[[@B41],[@B43]\].

Patient 2 and his maternal relatives are carriers of an atypical duplication that maps distal within the TDR. Unlike common duplications \[[@B43],[@B63],[@B73]\], this novel rearrangement, the smallest one reported to date, has therefore unknown clinical implications. Polymorphisms and copy number variants can be defined as alterations of a small region known to contain no critical genes and that can be inherited from healthy individuals \[[@B41],[@B43]\]. However, as proposed for *TBX1*, other genes in 22q11.2 may have clinical significance when present in a trisomic dosage \[[@B43],[@B74],[@B75]\]. On the other hand, four other carriers of the family of Patient 2 show normal phenotype, and the patient shows cleft palate, a potentially multifactorial malformation which may be less associated with 22q11.2 duplications than thought \[[@B40]\]. The case that is most similar to this duplication was described by Fan *et al*\[[@B76]\] in a patient with mental retardation or developmental delay associated to other malformations, inherited from a phenotypically normal father. This 479 kb duplication also included *PCQAP*, another gene with a potential involvement in schizophrenia susceptibility \[[@B77],[@B78]\].

Novel and rare rearrangements in such a complex chromosomal region with highly uncertain phenotypic consequences, have uncertain implications for genetic counseling. High intrafamilial variability and reduced penetrance are phenotypic effects that hamper the distinction between pathologic change and polymorphism \[[@B79]\]. In this context, the possibility that the phenotypes of our patients might not be caused by the observed rearrangements should be reminded. Also, small deletions and duplications occurring from generation to generation in this rearranged segment cannot be excluded \[[@B80]\].

Despite having occurred in the same region, our two rearrangements, as far as they have been molecularly characterized, are significantly different (Figure [4](#F4){ref-type="fig"}). The deletion is more than twice the size of the duplication and includes *HIC2*and the whole LCRs C and D, which are nearly intact in the duplication. This variation in the breakpoints location highlights potential differences in the molecular mechanisms mediating these rearrangements. In fact, the deletion is too large to be a C-D rearrangement and is possibly not mediated by non-allelic homologous recombination between LCRs.

Even for identical rearrangements, genetic counseling and clinical prognosis is still complex. Genotype-phenotype correlations made so far in 22q11.2 are compatible with a clinical outcome modified by environmental/stochastic events \[[@B15],[@B60],[@B61]\] and eclipsed by regulatory factors \[[@B15],[@B59]\]. At this moment, the molecular diagnostic techniques we have used are the best screening procedure for patients with this whole spectrum of overlapping clinical features, suspected of having any kind of rearrangement in 22q11.2 resulting in a copy number imbalance \[[@B71],[@B81],[@B82]\].

Conclusion
==========

In summary, we report on the third atypical deletion and the first atypical duplication in the vicinity of low-copy repeats C and D in distal 22q11.2 deletion region. The breakpoints location and sizes make it possible that both rearrangements may be mediated by different mechanisms or sequences. A complex network of modifying factors may influence the phenotypic outcome of these chromosomal aberrations. A systematic literature review and genotyping of phenotype-associated polymorphisms can help anticipating the clinical evolution of patients and understanding the prognosis and predisposition to this disease.
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